Your go-to
radiopharmaceutical resource

To kick off 2025, we’re looking back at the radiopharma advancements and challenges that shaped 2024 and laid the groundwork for even greater progress in the year ahead. Here’s a…

At Nucleus RadioPharma, there’s nothing we enjoy more than educating our community on the latest advancements in radiopharmaceuticals, which is why we recently hosted two live events with top experts…

Radiopharmaceuticals present unique barriers to entry, largely due to the interplay between radioactive materials, short shelf life, stringent regulations, and intricate manufacturing processes. Operationally, radiopharmaceuticals require a level of precision…

Unlike more traditional pharmaceuticals with well-established manufacturing supply chains, radiotherapies have unique challenges and complexities to consider before choosing a contract development and manufacturing organization (CDMO) partner. The short shelf-life…

Jennifer Vogel's journey into the radiopharmaceutical industry is one of curiosity and passion, sparked by a unique opportunity at a Boston conference.  There, she heard from leading experts about Nucleus…

While radiotherapies hold great potential in the fight against cancer, organizations bringing these products to patients face significant challenges, especially related to manufacturing and distribution. Unlike traditional pharmaceuticals, radiopharmaceutical therapies…

While some may associate radiopharmaceuticals with recent innovations, clinical use dates back more than 80 years, with the pioneering application of radioactive iodine for thyroid conditions and cancer. This early…

Radiopharmaceuticals are specialized drugs that use radioactive isotopes to diagnose and treat various medical conditions, most notably cancer. These drugs differ from other available treatment and diagnostic methodologies as they…